Shalini N. Jhangiani

Shalini N. Jhangiani

Auto-generated profile, based on publicly available information

Shalini N. Jhangiani

Human Genome Sequencing Center, Baylor College of Medicine

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 July 2020 in Science
Verified
Journal Article
Closed access
PDF file
SCSarah A. Cook
Sarah A. Cook
WCWilliam A. Comrie
William A. Comrie
Cecilia Poli-HarloweCecilia Poli-Harlowe
Cecilia Poli-Harlowe
MSMorgan Similuk
Morgan Similuk
AOAndrew J. Oler
Andrew J. Oler
MLMichael J. Lenardo
Michael J. Lenardo
An inherited disorder makes WAVEs: The WAVE regulatory complex (WRC) is a multiunit complex that regulates actin cytoskeleton formation. Although other actin-regulatory proteins modulate human immune responses, the precise role for the WRC has not yet been established. Cook et al. studied five patients from four unrelated families who harbor missense variants of the gene encoding the WRC component HEM1. These patients presented with recurrent infections and poor antibody responses, along with enhanced allergic and autoimmune disorders. HEM1 was found to be required for the regulation of cortical actin and granule release in T cells and also interacted with a key metabolic signaling complex contributing to the disease phenotype. By linking these interactions to immune function, this work suggests potential targets for future immunotherapies. Science , this issue p. 202

16 July 2025 in Scientific Data
Verified
Journal Article
Open access
PDF file
JMJennifer H. McDaniel
Jennifer H. McDaniel
VPVaidehi Patel
Vaidehi Patel
NONathan Olson
Nathan Olson
HHHua-Jun He
Hua-Jun He
HZHe Zhiyong
He Zhiyong
JZJustin M. Zook
Justin M. Zook
The Genome in a Bottle Consortium (GIAB), hosted by the National Institute of Standards and Technology (NIST), is developing new matched tumor-normal samples, the first explicitly consented for public dissemination of genomic data and cell lines. Here, we describe a comprehensive genomic dataset from the first individual, HG008, including DNA from an adherent, epithelial-like pancreatic ductal adenocarcinoma (PDAC) tumor cell line and matched normal cells from duodenal and pancreatic tissues. Data for the tumor-normal matched samples comes from seventeen distinct state-of-the-art whole genome measurement technologies, including high depth short and long-read bulk whole genome sequencing (WGS), single cell WGS, Hi-C, and karyotyping. These data will be used by the GIAB Consortium to develop matched tumor-normal benchmarks for somatic variant detection. We expect these data to facilitate innovation for whole genome measurement technologies, de novo assembly of tumor and normal genomes, and bioinformatic tools to identify small and structural somatic variants. This first-of-its-kind broadly consented open-access resource will facilitate further understanding of sequencing methods used for cancer biology.

1 November 2018 in Molecular Genetics and Metabolism
Verified
Journal Article
Open access
JPJaya Punetha
Jaya Punetha
LMLoren Mackay-Loder
Loren Mackay-Loder
THTamar Harel
Tamar Harel
ZCZeynep Coban-Akdemir
Zeynep Coban-Akdemir
SJShalini N. Jhangiani
Shalini N. Jhangiani
JPJennifer E. Posey
Jennifer E. Posey
Charcot-Marie-Tooth (CMT) disease type 1 is an inherited peripheral neuropathy characterized by demyelination and reduced nerve conduction velocities. We present a multi-generational family with peripheral neuropathy in whom clinical CMT panel testing failed to conclude a molecular diagnosis. We found a PMP2 pathogenic variant c.155T > C, p.(Ile52Thr) that segregates with disease suggesting that PMP2 variants should be considered in patients with neuropathy and that it may be prudent to include in clinical CMT gene panels.

24 September 2022 in Human Mutation
Verified
Journal Article
Closed access
VCVaruna Chander
Varuna Chander
MMMedhat Mahmoud
Medhat Mahmoud
JHJianhong Hu
Jianhong Hu
ZDZain Dardas
Zain Dardas
CGChristopher M. Grochowski
Christopher M. Grochowski
RGRichard A. Gibbs
Richard A. Gibbs

10 February 2017 in Frontiers in Pediatrics
Verified
Journal Article
Open access
LPLuis Alberto Pedroza
Luis Alberto Pedroza
NGNina Guerrero
Nina Guerrero
ASAsbjorg Stray-Pedersen
Asbjorg Stray-Pedersen
CTCristina Tafur
Cristina Tafur
RMRoque Macias
Roque Macias
JOJordan S. Orange
Jordan S. Orange
Severe infections with Histoplasma capsulatum are commonly observed in patient with secondary immunodeficiency disorders. We presented a two and a half years old boy previously healthy, with disseminated cutaneous Histoplasmosis. Using Whole Exome Sequencing we found an indel mutation at the CD40LG gene, suggesting a diagnosis of Hyper IgM Syndrome, even in the absence of the usual features for the disease. Interestingly the patient lives in a region endemic for Histoplasmosis. The unusual infections in our case suggest that in children with severe histoplasmosis and resident in endemic areas, Hyper IgM Syndrome should be considered as a diagnosis.

4 October 2019 in Acta Cardiologica
Verified
Journal Article
Closed access
TRTomas Robyns
Tomas Robyns
RWRik Willems
Rik Willems
JCJohan Van Cleemput
Johan Van Cleemput
SJShalini Jhangiani
Shalini Jhangiani
DMDonna Muzny
Donna Muzny
ACAnniek Corveleyn
Anniek Corveleyn
Background: Familial dilated cardiomyopathy (DCM) is genetically heterogeneous and is associated with mutations in at least 40 different genes. Apart from TTN encoding the giant protein Titin, none of these genes have an expected diagnostic yield of more than 5% complicating genetic diagnosis. Whole exome sequencing (WES) is a powerful alternative for the identification of the causal gene, however variant interpretation remains challenging. We report on WES in a large family with autosomal dominant DCM complicated by end stage heart failure and non-sustained ventricular arrhythmias in whom no causative mutation was identified using a targeted gene panel including 28 genes. Methods and results: WES was applied on 2 affected cousins. Stringent filtering of the identified genetic variants was performed including population variant frequencies, in silico analysis, orthologous and paralogous conservation. Subsequently Sanger sequencing was performed for 10 potential disease causing variants in order to confirm the presence of the variant and to evaluate co-segregation. Only one variant in exon 9 of the RBM20 gene (c.2714T > A, p.Met950Lys, NM_001334363) showed full co-segregation in the 7 affected family members resulting in a maximum 2-point LOD score of 2.1 and suggesting this as the pathogenic mutation responsible for the phenotype. Recently mutations in RBM20 have been linked to arrhythmogenic dilated cardiomyopathy caused by defective splicing of the giant sarcomere protein titin and abnormal calcium handling. Conclusions: We report the identification of a novel mutation in RBM20 by WES in a large pedigree with DCM.